Your browser doesn't support javascript.
loading
Rationale and study protocol for a randomized controlled feeding study to determine the structural- and functional-level effects of diet-specific interventions on the gut microbiota of non-Hispanic black and white adults.
Carson, Tiffany L; Buro, Acadia W; Miller, Darci; Peña, Alissa; Ard, Jamy D; Lampe, Johanna W; Yi, Nengjun; Lefkowitz, Elliot; William, Van Der Pol; Morrow, Casey; Wilson, Landon; Barnes, Stephen; Demark-Wahnefried, Wendy.
Afiliación
  • Carson TL; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, United States of America. Electronic address: tiffany.carson@moffitt.org.
  • Buro AW; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, United States of America.
  • Miller D; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, United States of America.
  • Peña A; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, United States of America.
  • Ard JD; Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, NC, United States of America.
  • Lampe JW; Public Health Science Division, Fred Hutchinson Cancer Center, Seattle, WA, United States of America.
  • Yi N; Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, United States of America.
  • Lefkowitz E; Center for Clinical and Translational Sciences, University of Alabama at Birmingham, Birmingham, AL, United States of America; Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, United States of America.
  • William VP; Center for Clinical and Translational Sciences, University of Alabama at Birmingham, Birmingham, AL, United States of America.
  • Morrow C; Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, United States of America.
  • Wilson L; Department of Pharmacology and Toxicology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States of America; Targeted Metabolomics and Proteomics Laboratory, University of Alabama at Birmingham, Birmingham, AL, United States of America.
  • Barnes S; Department of Pharmacology and Toxicology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States of America; Targeted Metabolomics and Proteomics Laboratory, University of Alabama at Birmingham, Birmingham, AL, United States of America.
  • Demark-Wahnefried W; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, United States of America.
Contemp Clin Trials ; 123: 106968, 2022 12.
Article en En | MEDLINE | ID: mdl-36265810
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 3_ND Problema de salud: 1_doencas_nao_transmissiveis / 3_zoonosis Asunto principal: Microbioma Gastrointestinal Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Contemp Clin Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 3_ND Problema de salud: 1_doencas_nao_transmissiveis / 3_zoonosis Asunto principal: Microbioma Gastrointestinal Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Contemp Clin Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2022 Tipo del documento: Article